Skip to main content
EYPT
NASDAQ Life Sciences

EyePoint's Key Wet AMD Phase 3 Trials Remain on Track, Topline Data Expected Mid-2026

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$13.97
Mkt Cap
$1.152B
52W Low
$5.3
52W High
$19.11
52W Position info
164% above low
Off High info
27% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

EYPT has more than doubled off its 52-week low of $5.3.

Summary

EyePoint announced that its pivotal Phase 3 LUGANO and LUCIA trials for wet age-related macular degeneration (AMD) remain on track. This update confirms that the development program is progressing as expected, with no reported delays or issues. For a clinical-stage biotechnology company, maintaining the timeline for late-stage trials is crucial for investor confidence and future valuation. The company reiterated that topline data from these trials is anticipated to begin in mid-2026, which will serve as a significant catalyst for the stock.

At the time of this announcement, EYPT was trading at $13.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $5.30 to $19.11. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

EYPT - Latest Insights

EYPT
Nov 19, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.281969
Real-time Price: $0.2554 info
Change: -$0.026569 (-9%) info
Market Cap: $29.06M info
EYPT
Nov 12, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.350
Real-time Price: $0.2554 info
Change: -$0.0946 (-27%) info
Market Cap: $29.06M info
EYPT
Nov 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.360
Real-time Price: $0.2554 info
Change: -$0.1046 (-29%) info
Market Cap: $29.06M info
EYPT
Nov 12, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.360
Real-time Price: $0.2554 info
Change: -$0.1046 (-29%) info
Market Cap: $29.06M info
EYPT
Oct 19, 2026, 9:22 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5443
Real-time Price: $0.2554 info
Change: -$0.2889 (-53%) info
Market Cap: $29.06M info